STORM is open to collaboration opportunities to discover and validate new RNA Modifying Enzyme (RME) targets and to explore utilising our first in class inhibitors in new therapeutic applications. If you would like to learn more, want to join us, partner or collaborate, please contact info@stormtherapeutics.com 29th May 2022 - 2nd June 2022 | Castelldefels, Spain Professor Tony Kouzarides, STORM Therapeutics Founder & Director will be speaking on Monday 31st May at 7.05pm on "Modifications of RNA and Their Role in Cancer"Chromatin Structure and Function: Chromatin Modifications, RNA and Metabolism
